2^nd European Cardiology Congress August 21-22, 2020 Florence, Italy

Cardiovascular diseases (CVDs) comprise disorders and conditions related to circulatory system which include heart and vascular system. The global cardiovascular drugs market is anticipated to reach the value of approximately US$ 91.0 Bn by 2025. Drug classes used to treat cardiovascular indications such as hyperlipidemia, hypertension are likely to fuel expansion of the global cardiovascular drugs market from 2017 to 2025.

Cardiovascular diseases are one of the leading causes of death worldwide. According to American Heart Association, it is estimated that cardiovascular disease is likely to increase to 45% by 2035. Sedentary lifestyle, changing dietary habits and surge in associated risk factors are likely to increase the number of patients with cardiovascular diseases. According to the Centers for Disease Control and Prevention (CDC) of the U.S., high blood pressure, high cholesterol, and smoking are key risk factors for heart disease. About half of the population of the U.S. (47%) have at least one of these three risk factors. To treat the diseases, key players are investing in to develop new drugs with better efficacy and less side effects.

The global cardiac biomarker diagnostic test kits market is expected to be worth US$ 2,540.8 Mn in 2028, and is projected to increase at a CAGR of 5.1% through 2028. North America is expected to be a dominant market, which accounted for US$ 522.5 Mn in 2017, and is expected to grow at a CAGR of 4.3%. North America has been the dominant regional market for heart diagnostics with a share of approximately 47% of the overall heart diagnostics market in terms of revenue in 2016, followed by Europe which accounted for around 38% share in the market and then by Asia accounting for 15% share.

Scope and Importance: -
A prospective survey of patients with valvular heart disease (VHD):
Coronary angiography was used in 85.2% of patients before intervention.
The Euro Heart Survey (EHS) programme has been initiated order to provide quantitative information on cardiovascular disease.
To prevent the incidence of cardiovascular (CV) disease, by implementing strategies to reduce the burden of CV risk factors and incidence of CV disease and
develop appropriate models for healthy CV lifestyle.

The global cardiovascular therapeutics market continues to see rapid innovation with new drugs and devices entering the market. According to our cardiovascular market research experts, diabetes is one of the major factors leading to the current cardiovascular disease epidemic. The growing prevalence of chronic diseases such as diabetes is the major factor leading to the growth of the heart failure market. Due to the potential breakthrough of newly approved drugs entering the market, heart failure market size is expected to grow in the coming years.

Cardiovascular Drugs Market

Major players in the global Cardiovascular drugs market include Merck & Co, Sanofi S.A, Pfizer Inc, Bristol-Myers Squibb Company, Novartis AG. The cardiovascular drugs market expected to reach a value of nearly $86.67 billion by 2022, significantly growing at a CAGR of 1.2% during the forecast period. The growth in the Cardiovascular drugs market is due to increase in aging population, increase in the prevalence of cardiovascular diseases and availability of more generic drugs that reduce the cost of treatment. Among the drugs used to treat cardiovascular diseases, the heart failure drugs market is one in particular expected to witness strong growth through 2022 due to the growing prevalence of chronic diseases such as diabetes. The global hypertension drugs market will post an impressive market value of  USD 32 billion by the end of 2020. The prevalence of hypertension is high among the older population with close to 70% of the patients with high BP above the age of 60.

Cardiovascular Ultrasound Devices Market Size and Growth Opportunities:

The ultrasound market is projected to reach USD 8.4 billion by 2023 from USD 6.3 billion in 2018, at a CAGR of 5.9% during the forecast period. Factors such as the increasing prevalence of target diseases, rising patient preference for minimally invasive procedures, technological advancements, increasing number of diagnostic centers & hospitals, and growing public and private investments, funding, and grants are driving the growth of the market during the forecast period. Cardiac Ultrasound System are the devices that are used in taking out live images or pictures of the heart. The clear images are used in early detection of cardiovascular diseases. There are several types of procedures relating to Cardiac ultrasound that includes transthoracic echocardiograph, 3D echocardiograph, electrocardiograph etc. Key players in the Cardiac Ultrasound Market : Canon Medical Systems Corporation; Koninklijke Philips N.V.; Hitachi; Fujifilm Medical Systems; GE Healthcare, Inc.; Siemens Healthcare; Kalamed Medical Systems; Chison Medical IMaging Co. Ltd.; Samsung Medison and Mindray Medical

The global medicine market includes interventional, internal organ devices. The worldwide interventional medicine devices market has been expected to understand $25.16 billion by 2020. On the opposite hand, the Asia Pacific market is anticipated to travel on top of $6.4 billion by 2022.

The global cardiovascular device industry is growing rapidly and exhibits signs that it will continue to evolve and expand.

Congenital Heart Disease and Pediatrics

Cardiovascular Disease, Risk factors and Nutrition

Cardiac Imaging

Valvular Heart Disease

Coronary Heart Diseases

Cardiac Remodeling or Ventricular Remodeling

Cardiac Diagnostic Test

Cardiometabolic Health- Diabetes, Obesity & Metabolism

Cardiothoracic Surgery

Cardiac Toxicity

Cardiovascular Imaging-MRI, CT, Nuclear Medicine

Pediatric Cardiac Nanomedicine

Cardiology Case Reports

Myocarditis and Cardiomyopathies

Pediatric Heart Transplantation

Cardiac Pharmacology

Molecular Cardiology

Current research on Cardiology - Future Medicine

Cardio-Oncology and Nuclear Cardiology

Cardiac Nursing: Acute and Chronic Cardiac Care

Lipidology & Preventive Cardiology

Hypertension and Healthcare

Cardiovascular Engineering and Technology

Catheterization and Cardiovascular Interventions

Nephrocardiology

Electrocardiography

Cardiac Surgery

Stem Cell Research and Regeneration on Cardiology

Cardiac Anaesthesiology